Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy

Biochemical and Biophysical Research Communications

Volumn 428, Issue 3, 2012, Pages 339-342

  Iwatani, Hirotsugu ^a   Inoue, Takahiro ^a   Wada, Yoshinao ^b   Nagasawa, Yasuyuki ^c   Yamamoto, Ryohei ^a   Iijima, Hideki ^a   Takehara, Tetsuo ^a   Imai, Enyu ^d   Rakugi, Hiromi ^a   Isaka, Yoshitaka ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d Nakayamadera Imai Clinic   (Japan)

Author keywords

Galactose; IgA nephropathy (IgAN); Mass spectrometry; N acetylgalactosamine (GalNAc); O glycosylation; Tonsil; Tonsillectomy

Indexed keywords

CORTICOSTEROID; GALACTOSE; GLYCAN; IMMUNOGLOBULIN A; N ACETYLGALACTOSAMINE;

ADULT; ARTICLE; CHEMICAL COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REMISSION; TONSILLECTOMY;

ACETYLGALACTOSAMINE; ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; BIOLOGICAL MARKERS; FEMALE; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; MALE; POLYSACCHARIDES; TONSILLECTOMY; YOUNG ADULT;

EID: 84869878868     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.049     Document Type: Article

References (20)

1. Pettersson E. IgA nephropathy: 30 years on. J. Intern. Med. 1997, 242(5):349-353.
2. Masuda Y., Terazawa K., Kawakami S., Ogura Y., Sugiyama N. Clinical and immunological study of IgA nephropathy before and after tonsillectomy. Acta Otolaryngol. Suppl. 1988, 454:248-255.
3. Akagi H., Nishizaki K., Hattori K., Kosaka M., Fukushima K., Doi A., Masuda Y. Prognosis of tonsillectomy in patients with IgA nephropathy. Acta Otolaryngol. Suppl. 1999, 540:64-66.
4. Hotta O., Miyazaki M., Furuta T., Tomioka S., Chiba S., Horigome I., Abe K., Taguma Y. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am. J. Kidney Dis. 2001, 38(4):736-743.
5. Miyazaki M., Hotta O., Komatsuda A., Nakai S., Shoji T., Yasunaga C., Taguma Y. A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy: a 5-year report. Contrib. Nephrol. 2007, 157:94-98.
6. Komatsu H., Fujimoto S., Hara S., Sato Y., Yamada K., Kitamura K. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin. J. Am. Soc. Nephrol. 2008, 3(5):1301-1307.
7. Xie Y., Nishi S., Ueno M., Imai N., Sakatsume M., Narita I., Suzuki Y., Akazawa K., Shimada H., Arakawa M., Gejyo F. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003, 63(5):1861-1867.
8. Hiki Y., Odani H., Takahashi M., Yasuda Y., Nishimoto A., Iwase H., Shinzato T., Kobayashi Y., Maeda K. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 2001, 59(3):1077-1085.
9. Allen A.C., Bailey E.M., Brenchley P.E., Buck K.S., Barratt J., Feehally J. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int. 2001, 60(3):969-973.
10. Kokubo T., Hiki Y., Iwase H., Tanaka A., Toma K., Hotta K., Kobayashi Y. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J. Am. Soc. Nephrol. 1998, 9(11):2048-2054.
11. Allen A.C., Harper S.J., Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin. Exp. Immunol. 1995, 100(3):470-474.
12. Tomana M., Matousovic K., Julian B.A., Radl J., Konecny K., Mestecky J. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 1997, 52(2):509-516.
13. Hiki Y., Iwase H., Kokubo T., Horii A., Tanaka A., Nishikido J., Hotta K., Kobayashi Y. Association of asialo-galactosyl beta 1-3N-acetylgalactosamine on the hinge with a conformational instability of Jacalin-reactive immunoglobulin A1 in immunoglobulin A nephropathy. J. Am. Soc. Nephrol. 1996, 7(6):955-960.
14. Allen A.C., Bailey E.M., Barratt J., Buck K.S., Feehally J. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J. Am. Soc. Nephrol. 1999, 10(8):1763-1771.
15. Hiki Y., Tanaka A., Kokubo T., Iwase H., Nishikido J., Hotta K., Kobayashi Y. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J. Am. Soc. Nephrol. 1998, 9(4):577-582.
16. Odani H., Hiki Y., Takahashi M., Nishimoto A., Yasuda Y., Iwase H., Shinzato T., Maeda K. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem. Biophys. Res. Commun. 2000, 271(1):268-274.
17. Wada Y., Tajiri M., Ohshima S. Quantitation of saccharide compositions of O-glycans by mass spectrometry of glycopeptides and its application to rheumatoid arthritis. J. Proteome Res. 2010, 9(3):1367-1373.
18. Inoue T., Iijima H., Tajiri M., Shinzaki S., Shiraishi E., Hiyama S., Mukai A., Nakajima S., Iwatani H., Nishida T., Mizushima T., Yasui T., Isaka Y., Kanto T., Tsujii M., Miyoshi E., Wada Y., Takehara T. Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease. Inflamm. Bowel Dis. 2012, 18(9):1723-1734.
19. Gharavi A.G., Moldoveanu Z., Wyatt R.J., Barker C.V., Woodford S.Y., Lifton R.P., Mestecky J., Novak J., Julian B.A. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J. Am. Soc. Nephrol. 2008, 19(5):1008-1014.
20. Horie A., Hiki Y., Odani H., Yasuda Y., Takahashi M., Kato M., Iwase H., Kobayashi Y., Nakashima I., Maeda K. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am. J. Kidney Dis. 2003, 42(3):486-496.